Kegeles LS, Shungu DC, Anjilvel S, Chan S, Ellis SP, Xanthopoulos E, Malaspina D, Gorman JM, Mann JJ, Laruelle M et al..
2000.
Hippocampal pathology in schizophrenia: magnetic resonance imaging and spectroscopy studies.. Psychiatry Res. 98(3):163-75.
Bobinski M, de Leon MJ, Wegiel J, DeSanti S, Convit A, Louis LASaint, Rusinek H, Wisniewski HM.
2000.
The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease.. Neuroscience. 95(3):721-5.
Koutcher JA, Motwani M, Zakian KL, Li XK, Matei C, Dyke JP, Ballon D, Yoo HH, Schwartz GK.
2000.
The in vivo effect of bryostatin-1 on paclitaxel-induced tumor growth, mitotic entry, and blood flow.. Clin Cancer Res. 6(4):1498-507.
Wehrle JP, Ng CE, McGovern KA, Aiken NR, Shungu DC, Chance EM, Glickson JD.
2000.
Metabolism of alternative substrates and the bioenergetic status of EMT6 tumor cell spheroids.. NMR Biomed. 13(6):349-60.
Lewin M, Carlesso N, Tung CH, Tang XW, Cory D, Scadden DT, Weissleder R.
2000.
Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells.. Nat Biotechnol. 18(4):410-4.
Zaider M, Zelefsky MJ, Lee EK, Zakian KL, Amols HI, Dyke J, Cohen G, Hu Y, Endi AK, Chui C et al..
2000.
Treatment planning for prostate implants using magnetic-resonance spectroscopy imaging.. Int J Radiat Oncol Biol Phys. 47(4):1085-96.